Circulation of respiratory viruses during the COVID-19 pandemic in The Gambia

Copyright: © 2023 Jarju S et al..

Background: In many countries, non-pharmaceutical interventions to limit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission resulted in significant reductions in other respiratory viruses. However, similar data from Africa are limited. We explored the extent to which viruses such as influenza and rhinovirus co-circulated with SARS-CoV-2 in The Gambia during the COVID-19 pandemic.  Methods: Between April 2020 and March 2022, respiratory viruses were detected using RT-PCR in nasopharyngeal swabs from 1397 participants with influenza-like illness. An assay to detect SARS-CoV-2 and a viral multiplex RT-PCR assay was used as previously described  to detect influenza A and B, respiratory syncytial virus (RSV) A and B, parainfluenza viruses 1-4, human metapneumovirus (HMPV), adenovirus, seasonal coronaviruses (229E, OC43, NL63) and human rhinovirus. Results: Overall virus positivity was 44.2%, with prevalence higher in children <5 years (80%) compared to children aged 5-17 years (53.1%), adults aged 18-50 (39.5%) and >50 years (39.9%), p<0.0001. After SARS-CoV-2 (18.3%), rhinoviruses (10.5%) and influenza viruses (5.5%) were the most prevalent. SARS-CoV-2 positivity was lower in children <5 (4.3%) and 5-17 years (12.7%) than in adults aged 18-50 (19.3%) and >50 years (24.3%), p<0.0001. In contrast, rhinoviruses were most prevalent in children <5 years (28.7%), followed by children aged 5-17 (15.8%), adults aged 18-50 (8.3%) and >50 years (6.3%), p<0.0001. Four SARS-CoV-2 waves occurred, with 36.1%-52.4% SARS-CoV-2 positivity during peak months. Influenza infections were observed in both 2020 and 2021 during the rainy season as expected (peak positivity 16.4%-23.5%). Peaks of rhinovirus were asynchronous to the months when SARS-CoV-2 and influenza peaked. Conclusion: Our data show that many respiratory viruses continued to circulate during the COVID-19 pandemic in The Gambia, including human rhinoviruses, despite the presence of NPIs during the early stages of the pandemic, and influenza peaks during expected months.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:6

Enthalten in:

Gates open research - 6(2022) vom: 28., Seite 148

Sprache:

Englisch

Beteiligte Personen:

Jarju, Sheikh [VerfasserIn]
Senghore, Elina [VerfasserIn]
Brotherton, Helen [VerfasserIn]
Affleck, Lucy [VerfasserIn]
Saidykhan, Alasana [VerfasserIn]
Jallow, Samba [VerfasserIn]
Krubally, Ebrima [VerfasserIn]
Sinjanka, Edrisa [VerfasserIn]
Ndene, Morris Ngor [VerfasserIn]
Bajo, Fabakary [VerfasserIn]
Sanyang, Musa M [VerfasserIn]
Saidy, Binta [VerfasserIn]
Bah, Alasana [VerfasserIn]
Mohammed, Nuredin I [VerfasserIn]
Forrest, Karen [VerfasserIn]
Clarke, Ed [VerfasserIn]
Dalessandro, Umberto [VerfasserIn]
Sesay, Abdul K [VerfasserIn]
Usuf, Effua [VerfasserIn]
Cerami, Carla [VerfasserIn]
Roca, Anna [VerfasserIn]
Kampmann, Beate [VerfasserIn]
de Silva, Thushan I [VerfasserIn]

Links:

Volltext

Themen:

Influenza like illness
Journal Article
Respiratory viruses
SARS-CoV-2
Surveillance

Anmerkungen:

Date Revised 13.03.2024

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.12688/gatesopenres.14155.3

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM352369868